Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 121 Lymphoid 98 Myeloid 72 Plasma cell 56 Classical hematology 22 Other neoplasm 5 Genitourinary 3 Dermatologic 3 CNS 3 Thoracic 2 Sarcoma 2 Other 1 Gastrointestinal 1 Breast 1

Conditions

Obesity 410 Neoplasms 151 Mucositis 128 Sexual Dysfunction, Physiological 105 Breast Neoplasms 105 Polycystic Ovary Syndrome 98 Overweight 98 Dyspnea 62 Constipation 57 Motor Activity 54 Head and Neck Neoplasms 47 Prostatic Neoplasms 42 Weight Loss 39 Diabetes Mellitus 36 Pain 34 Colorectal Neoplasms 33 Opioid-Induced Constipation 29 Endometrial Neoplasms 29 Stomatitis 28 Lung Neoplasms 28 Depression 26 Diabetes Mellitus, Type 2 24 Cardiovascular Diseases 23 Obesity, Morbid 22 Multiple Endocrine Neoplasia Type 1 22 Insulin Resistance 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 21 Anxiety Disorders 21 Hypertension 19 Sexual Dysfunctions, Psychological 18

Interventions

Surveys and Questionnaires 1 Sugars 1 Dexamethasone 1 Calcium Dobesilate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hematologic Diseases × Other × Clear all

NCT01670097 2021-02-17

Dexamethasone Dyspnea Study

M.D. Anderson Cancer Center

Phase 2 Completed

52 enrolled 13 charts

Dyspnea, Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡